Category health

July 15, 2025: Fischer Medical Ventures Ltd (FMV) proudly announced a landmark public-private initiative in partnership with the City of Jember, Indonesia, supporting the city with multiple portable, AI-enabled digital X-ray systems designed for mobility, low-radiation exposure, and rapid diagnostics to help “Free Tuberculosis (TB) in Jember” by 2026, and to further FMV’s commitment to help Indonesia achieve their national goal to eradicate TB by 2030.

For the Company, this initiative is not just exercising its corporate social responsibility, it is a strategic move into a 280 million population country with huge opportunities from its public health plans, especially to fight TB, an infectious disease that can lead to death if not treated promptly. Indonesia continues to battle one of the highest burdens of TB in the world, alongside India and China. A key challenge remains: limited access to early detection and treatment. For many TB patients in Indonesia, the journey to diagnosis often begins with a long wait, and a long difficult walk from remote villages nestled in mountains or coastal towns cut off by poor infrastructure. For someone coughing for weeks, gasping for breath, and unsure whether it’s TB or something else, getting to a hospital miles away is a battle they often lose.

Championed by Regent Muhammad Fawait of Jember, this public-private partnership with FMV aims to put Jember citizen at the centre. FMV will support multiple units of portable AI- driven X-Ray, training programs and a comprehensive “Trace, Test, Track” solution to fast-track progress towards a TB-free Jember by ensuring its citizens gain access to early detection, get timely treatment, and receive sustained care. In a country where TB is the fourth leading cause of death, FMV’s comprehensive TB solution is changing lives—one patient, one diagnosis at a time, starting with Jember city and rolling out to partner more cities subsequently to help their citizens.

FMV’s handheld X-Ray combines mobility, speed, and AI to make healthcare more accessible. Its low radiation, portability, and AI diagnostics make it ideal for rural and underserved areas. Weighing under 3kg, FMV’s handheld X-Ray is a significant upgrade from typical bulky, 250kg X-Ray used in TB screening. With this lightweight device, healthcare teams can now reach previously inaccessible areas, from mountain villages to coastal settlements, allowing more agile and efficient service delivery to act faster, reach further, and detect more cases. What makes it truly revolutionary is not just its size, but its AI-powered diagnostic support. With built-in algorithms trained to detect signs of TB in chest X-Rays, frontline health workers can now instantly flag suspected cases, reducing unnecessary sample collection and cutting down the time to diagnosis and treatment, save lives by speeding up everything!

With this program, FMV is positioning itself as a trusted partner in Indonesia’s healthcare transformation, opening pathways to future collaborations with government health bodies, and building emotional connection and goodwill with over 280 million citizens.

Indonesia Minister of Health, Budi Gunadi Sadikin, expressed his support for the program: “It’s excellent that the Regent of Jember is implementing President Prabowo’s Quick Win Program for Tuberculosis Eradication through the locally-led initiative ‘JEMBER TB-Free 2026.’ I fully support this initiative and hope it will inspire other districts and cities across Indonesia to follow Jember City’s lead.”

Executive Chairman & MD of Fischer Medical Ventures Ltd, Ravindran Govindan, lead this project: “When we support healthier communities, we’re not only doing what is right—we’re building a foundation for long-term prosperity and global trust with Indonesian citizens. For shareholders, it signals strategic entry and brand loyalty in high-potential public sector markets that can lead to long-term procurement relationships by enhancing trust among key stakeholders including government ministries, public hospitals, and global health funders.”

While Indonesia has made encouraging strides in TB detection, reporting, and treatment, with marked improvements since 2020, significant challenges—like drug-resistant TB, under- reporting in private sectors, and incomplete surveillance—should continue to be addressed. As Indonesia marches ahead towards a healthier, more resilient future, FMV remains proud to walk alongside its people—one step, one life, one cure at a time. Supporting Healthcare means going where people are, technology like FMV’s handheld AI-driven X-Ray brings access, speed, and accurate diagnostics to support Indonesia’s goal to end TB.

For the thousands of children who miss school, the breadwinners who can’t work, and the families left grieving, the support from FMV represents more than resources—it represents hope and reinforces the idea that when corporations stand with countries, change becomes not just possible, but inevitable.

New Delhi, July 12, 2025: The second edition of the India Health Exhibition 2025, organised by Informa Markets in India, was inaugurated today at Bharat Mandapam, New Delhi, highlighting the rising demand and immense potential in this sector. The three-day event, which concludes on 13th July 2025, returns with renewed vigour and an expanded focus to drive collaboration, innovation, and knowledge sharing across India’s healthcare and MedTech sectors. It offers a vibrant setting for business, innovation, and industry change. In keeping with the times, India’s health-tech sector is set for significant expansion, with hiring projected to rise by 15–20% in 2025–26, reflecting the increasing demand for innovative healthcare solutions and the integration of technology in medical services.

The inaugural ceremony witnessed the presence of dignitaries such as Dr. Jitendra Sharma, MD, Founder CEO, AMTZ; Dr. Girdhar Gyani, Director General, Association of Healthcare Providers India; Mr. Rajiv Nath, Managing Director, Hindustan Syringes & Medical Device Ltd & Forum Coordinator, AIMED; Ms. Veena Kohli, CEO, Vanguard Diagnostics (P) Limited, Immediate Past President – ADMI; Mr. Himanshu Baid, Managing Director, Poly Medicure, and Vice President, NATHEALTH; Mr. Yogesh Mudras, Managing Director, Informa Markets India; Mr. Gop Menon, CFO, Informa Markets IMEA; and Mr. Rahul Deshpande, Senior Group Director, Informa Markets India.

Mr. Yogesh Mudras, Managing Director, Informa Markets in India, said, “Healthcare will always remain a national priority—and India is witnessing a decisive shift in this space. With a thriving population, a proactive government, and growing emphasis on self-care, the sector is moving toward a projected $638 billion valuation by 2030. Our medical tourism market too is set to reach $16.21 billion.

The India Health Exhibition, built on the strong legacy of WHX Dubai, brings together policy, innovation, and enterprise—with India at the centre. This year, our dual-track conferences, including the Global MedTech Connect, aim to spark deeper engagement and forward-looking discussions. And with the launch of the India HealthNext Awards, we are reinforcing our long-term commitment to recognising excellence across the healthcare value chain.”

Dr. Jitendra Sharma, MD, Founder and CEO of AMTZ, announced the launch of the world’s first dedicated Medical Technology University at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam. This pioneering institution will offer advanced degrees such as M.Tech, MBA, and Ph.D. in medical technology, aiming to transform the industry’s skill-building ecosystem. Supported by prominent industry leaders, including Mr. Rajiv Nath, Managing Director, Hindustan Syringes & Medical Device Ltd & Forum Coordinator AIMED (Association of Medical Device Industry), Mr. Suresh Vazirani, Founder Chairman, Erba Transasia, and Dr. Girdhar Gyani, Director General, AHPI (Association of Healthcare Providers India) the university will serve as a global centre for innovation, research, and high-quality manufacturing expertise. By fostering strong collaboration between industry, academia, and regulators, this initiative is set to strengthen India’s self-reliance, boost exports, and establish the country as a leading destination for advanced medical device manufacturing.

The 2025 edition of the show brings together over 300 leading brands representing the full spectrum of healthcare, including medical equipment and devices, diagnostics, orthopaedics, IT systems, infrastructure, and wellness solutions. This edition is expected to exceed the participation of more than 8,000 professionals including biomedical engineers, radiologists, pathologists, hospital procurement heads, clinicians, R&D professionals, and medical technology regulators. With 95% domestic and 5% international representation, India Health 2025 also saw participation from countries such as Italy, UAE, and Ethiopia. With a strong focus on the Startup India mission, this year featured a dedicated Startup and Medical Laboratory Pavilion along with a B2B Matchmaking App designed to streamline buyer-seller engagement.

The opening day of India Health 2025 featured two robust and parallel knowledge forums: Global MedTech Connect (July 11 & 12) and the healthcare knowledge conference – Healthcare 360° (July 11, 12 & 13).

Under the theme “Transforming MedTech: Pioneering Innovation and Global Compliance,” Global MedTech Connect brought together industry experts to explore themes such as regulatory reform, quality compliance, artificial intelligence in MedTech, cybersecurity, and sustainability. The sessions also included discussions on navigating geopolitical storms, the role of QMS for MedTech organizations in India: ISO 13485 and Indian MDR alignment, the role of BIS in the MedTech quality ecosystem, cultivating a culture of excellence in medical device manufacturing, sourcing quality raw materials for manufacturers, streamlining labelling compliance in India: a unified approach, strengthening India’s medical device regulatory system through IMDRF membership, and medical device cybersecurity: a checklist or a culture?

Simultaneously, the healthcare knowledge conference under the Healthcare 360° theme—integrating technology, tradition, and transformation—delivered keynote panels and presentations that focused on public health integration, local manufacturing, diagnostics, and hospital innovation. Topics included government initiatives such as pushing digital diagnostics, bridging government & diagnostics, running paperless hospitals using smart technology for better care, driving procurement access and transparency through GeM, making India an export capital of medical devices, and where human touch meets high tech.

The speaker lineup featured thought leaders from leading companies such as Fortis, Transasia Bio-Medicals, BPL Medical Technologies Pvt Ltd, GE Healthcare, Medicover Hospitals, Danaher Corporation, Apex Hospitals, BIORx Venture Advisors, MTaI, and Sarvodaya Hospitals.

A special white paper was also launched today by Praxis Global Alliance in collaboration with Informa Markets in India, providing insights into the increasing popularity of single speciality hospitals as a model to solve inherent challenges in the sector.

The India Health Exhibition 2025 is supported by industry bodies such as AIMED, ADMI, AHPI, EPCMD, and MTAI, ensuring it remains aligned with both sectoral priorities and the country’s broader goals under the ‘Make in India’ and ‘Digital Health Mission’ agendas.

July 11th 2025 – As Delhi & NCR experience ‘feels like’ temperatures exceeding 44°C with dust storms and sudden rains, and cities like Mumbai and Hyderabad face intense monsoons and rising viral infections, doctors are warning of an overlooked risk – non-diarrheal dehydration.

Across India, clinicians report a surge in patients recovering from fever or viral illness, still suffering from fatigue, cramps, low appetite, and brain fog. These are not just residual symptoms they signal fluid, electrolyte, and energy depletion that plain water may not be able to correct.

While dehydration is often linked to diarrhoea, experts are seeing it in heat exhaustion, dengue, fever, and respiratory/urinary tract infections conditions where the body loses salts and glucose along with fluids. This leads to delayed recovery, weakened immunity, and ongoing discomfort.

“Patients often believe recovery ends when fever subsides, but many return feeling drained and mentally foggy,” said Dr Abdul Majid Khan, Senior Consultant, Internal Medicine.
“These are signs of hidden dehydration that water alone can’t fix. In today’s climate, we must treat hydration proactively, with fluids, salts, and glucose from Day One.”

Doctors are turning to Fluid, Electrolyte, and Energy (FEE) therapy ready-to-drink (RTD) solutions combining electrolytes and glucose. These have shown to support to reduce fatigue and improve hydration in non-diarrheal cases, often within hours. Starting FEE therapy early helps prevent complications and helps shortens recovery time.

In 2024, Kenvue, the world’s largest consumer health company and makers of ORSL, launched ‘The Hydration Gap for Non-Diarrheal Illnesses’. The report highlighted FEE’s role in recovery from fever, heat illness, and viral infections. 87% of doctors agreed that oral FEE recommendation can improve the speed of recovery & that Ready to Drink (RTD) solutions can cut recovery time by up to 4.38 days,.

“Dehydration isn’t just about diarrhoea—it’s a condition which can occur even in fever and viral illness,” said Dr Manoj Chawla, Consultant Diabetologist. “Even without obvious fluid loss, patients can be significantly depleted. Structured FEE therapy must be part of early treatment, not an afterthought start FEE therapy alongside other medications from Day One,”.
“Water or ORS powders don’t act fast enough. RTD FEE solutions are more effective, well-tolerated, and help patients bounce back quicker. They’ve become a standard in my treatment protocol. .”

Those most at risk include elderly individuals, children, and working adults exposed to erratic weather. Signs like dizziness, weakness, or cramps are frequently overlooked until they escalate.

While WHO ORS remains the gold standard for diarrhea-related dehydration, experts point out that it may not fully address the compliance and palatability challenges in non-diarrheal scenarios—especially among children or elderly patients. In response, the healthcare market has seen the development of standardized, palatable FEE-electrolyte solutions provide better patient outcomes.

Kenvue India continues to work with healthcare professionals to advance scientifically formulated hydration practices. As weather-related health risks rise, replenishing fluids, salts, and energy is no longer optional—it’s essential to faster recovery.

Greater Noida West, 10th July 2025 – Reinforcing its commitment to harness innovation and clinical excellence, Sarvodaya Hospital, Gaur City 2, Greater Noida West, announced the launch of the MISSO RJR ROBOT- an advanced, fully active robotic system for joint replacement surgery. The integration of this state-of-the-art technology marks a significant milestone in orthopaedic innovation, exemplifying Sarvodaya’s mission to provide advanced and accessible care. Furthermore, this advanced technology can transform outcomes for patients who suffer from joint pain as well as immobility, enabling a faster return to active living.

Robotic Joint Replacement Surgeries (RJR) are redefining the landscape of orthopaedic care, offering a transformative leap in surgical precision and patient outcomes. The advanced MISSO RJR Robot stands at the forefront of this innovation as a fully active robotic system, seamlessly integrating AI-driven, real-time 3D surgical planning and execution to achieve sub-millimetre accuracy in implant positioning while also enabling highly personalised, CT-based preoperative planning tailored to each patient’s unique anatomy. The system’s minimally invasive surgical approach results in reduced pain, less blood loss, and significantly faster recovery times for patients.

Dr. Anchit Uppal, Senior Consultant & Head – Orthopaedics & Joint Replacement, at Sarvodaya Hospital, Greater Noida said, “In India, the demand for joint replacement surgeries has risen sharply—recent studies indicate a 20–25% annual increase, largely due to an ageing population and the growing prevalence of osteoarthritis and lifestyle-related orthopaedic issues. Traditional surgeries can be time-consuming and often require longer hospital stays, which can impact patients’ mental health and overall recovery. Minimally invasive robotic procedures, on the other hand, reduce surgical trauma, minimise pain and blood loss, and enable a much quicker return to daily activities. The MISSO RJR Robot enables us to deliver world-class joint replacement procedures that are not only safer and faster but also tailored to each patient’s unique anatomy and needs.”

Dr. Ankur Singh, Senior Consultant & Head– Orthopaedics & Joint Replacement, at Sarvodaya Hospital, Greater Noida, said, “The integration of advanced robotic technology in joint replacement marks a significant advancement in orthopaedic surgery. This system provides surgeons with enhanced control, accuracy, and reproducibility throughout the procedure, allowing for optimal implant positioning and alignment. Such precision not only reduces intraoperative variability but also minimises tissue trauma, postoperative pain, and recovery time. Ultimately, this enables us to deliver highly individualised, evidence-based care that significantly improves functional outcomes and overall quality of life for our patients.”

Dr. Rakesh Gupta, Chairman, Sarvodaya Healthcare, stated, “We at Sarvodaya have always believed in harnessing innovation for better patient outcomes. We introduced North India’s first fully active joint replacement robot at our multispeciality Sarvodaya Hospital in Sector 8, Faridabad. Now, the introduction of the advanced RJR Robot at our Noida unit reflects our endeavour to deliver global standards of care locally and be at the forefront of medical technology. This advancement will bring independence, dignity, and trust in our patients”.

10 July 2025, Hyderabad: AIIMS Bibinagar and CIE (Centre for Innovation and Entrepreneurship, at IIIT Hyderabad) hosted the MedCare AI Impact Hackathon — a unique innovation challenge designed to empower doctors, medical students, and health researchers to tackle real-world clinical problems through deep tech research led innovation.

The day-long event saw participation from 17 shortlisted teams, representing doctors, medical faculty, researchers, and students. The program aimed to bridge clinical expertise with AI-driven research and development by nurturing healthcare innovations directly from the field. Launched as a grassroots initiative by AIIMS Bibinagar, the hackathon focused on building clinical tools, diagnostics, patient care apps, and new care delivery models.

Participants received intensive 1:1 mentorship, attended expert lectures, and collaborated with IIIT Hyderabad faculty and startups during the immersive sessions. The event featured two tracks – one for medical practitioners and another for med-tech researchers. Through table mentoring sessions, idea refinement workshops, and guided pitch preparation, participants translated practical challenges from their clinical environments into scalable AI-powered healthcare solutions.

The top five finalist ideas showcased smart dental diagnostics, post-RCT dental canal defect detection using ML/CV, Portable dental caries scanner, predictive analytics for patient care and surgical planning technologies.

Dr. Ahanthem Santa Singh, Executive Director of AIIMS Bibinagar, addressed the gathering, applauding the collaborative innovation model between AIIMS and IIITH.

Prof. Bapi Raju, Professor & Head Cognitive Sciences at IIIT Hyderabad, added: “The MedCare AI Impact Hackathon program demonstrates how deep tech research and clinical practice can intersect to create impactful healthcare innovation.”

Mr. Satish Kathirisetti, Seasoned Entrepreneur & Chief Mentor for medtech startups at CIE, added: “The MedCare AI Impact Hackathon reflects CIE’s vision of fostering innovation at the intersection of healthcare and technology. By empowering medical professionals to co-develop AI-driven solutions, we’re building a foundation for long-term impact in clinical practice and public health.”

The top winning teams will now be supported with: Access to a POC seed grant of ₹5 lakh; First prototype and tech/research support from IIIT-H research labs; Access to the joint CIE-AIIMS incubation track for continued mentoring and market discovery.

Annexure: The final 17 teams and ideas

AI Dent Triage – AI Dent multimodal AI triage platform designed to assist dentists by developing and validating clinical workflows that integrate intraoral photographs, RVG images, and OPG scans.

Neuro Risk – Neuro Risk is an AI-powered tool that analyzes dental X-rays to help dentists assess nerve injury risk before lower wisdom tooth surgeries. It automatically detects signs of nerve proximity using panoramic radiographs.

NeoScreen AI – NeoScreen AI is an AI-powered smartphone app for early EHBA detection, this solution analyzes stool images using deep learning. Built for rural India, it supports offline use, daily monitoring, and public health system integration.

Enamel Eyes – Portable Dental Aids – Aims to evaluate a customized portable dental caries detection aid by comparing its performance against clinical diagnoses, to support broader clinical adoption.

AI Network – AI Network is building a portable device that provides real-time monitoring of end-tidal CO₂ and respiratory flow, enabling accurate ventilation assessment in critical care, transport, and field settings.

Jam Avinya – Jam Avinya develops a machine learning model for diagnosing facial asymmetry using individually facial photographs and radiographs.

Snoozelad – Snoozelad is a low-cost, portable vital signs monitor with alerts designed for rural clinics to detect danger signs early and save lives.

Safeped AI – Safeped AI is an AI-powered Paediatric Surgical Safety Checklist tailored to the unique needs of paediatric surgery in India.

Theronex – Theronex is developing an AI-powered tool that delivers clinical-grade skin analysis at home using smartphone-based fluorescence imaging.

TMJ 3D View – TMJ 3D View is an Advanced algorithm for automated 3D segmentation of the Temporomandibular Joint (TMJ) and disc from MRI DICOM data, enabling faster diagnosis of TMDs and disc displacement by non-specialist clinicians.

Gluco Pulse: IoT Enabled Smart Self Diagnostic – Gluco Pulse is a Smart 3D-printed mouthguard prosthesis with embedded biosensors that continuously monitors salivary glucose levels &transmits real-time data to a smartphone app for non-invasive diabetes mgmt

Geriatric Care – detection of emotional stress – Developing an AI-powered system that integrates facial expressions, vocal tones, and physiological signals to detect emotional distress in elderly patients.

AI based Anemia Screening Device – A non-invasive anaemia screening tool that uses smartphone-based imaging and AI to detect anaemia in children aged 1 month to 18 years

AI Endo – Developing a Deep learning-based tool using YOLOv5 architecture to accurately segment second mesiobuccal (MB2) canals in maxillary molars from CBCT scans.

New Delhi, July 4, 2025: Clinic Dermatech has been recognised as India’s No. 1 Skin & Hair Clinic at the National Prestige Awards 2025, held at Radisson Blu, Dwarka. The award was presented by Ms. Esha Deol, who attended the ceremony as Chief Guest, along with several dignitaries and industry leaders.

This is the third consecutive year Clinic Dermatech has received national-level recognition. After being named the best skin and hair clinic by The Times of India for two years in a row, this latest award is another reminder of how committed the team is to delivering great results and helping people feel confident in their skin.

Over the years, Clinic Dermatech has become a trusted destination for people looking for real results and expert care. With more than 2.5 million sessions completed to date, advanced technology, and a team of skilled dermatologists, their clinics offer a wide range of treatments including laser hair reduction, anti-ageing solutions, skin rejuvenation, and hair restoration. The focus remains on delivering results through non-surgical treatments that are safe and comfortable. Clinic Dermatech has led the Laser Hair Reduction industry for 19 years, consistently delivering top-tier results with world-class technology and earning 95%+ client satisfaction, the highest in the category.

The National Prestige Awards are known for celebrating excellence across industries. For Clinic Dermatech, this win isn’t just reflective of its current standing but the growing role of aesthetic services in the broader health and wellness landscape.

Speaking at the event, Mr. Rajesh Singh, COO at Clinic Dermatech, said, “Winning the title of India’s No. 1 Skin & Hair Clinic three times in a row is more than an achievement, it’s a reflection of our consistency, our commitment, and the trust our clients place in us. In the world of beauty and wellness, consistency creates transformation. Wellness is the new luxury. Beauty is how it shines through. Our vision is clear- to keep this legacy alive, year after year.’’

With clinics across major Indian cities and a clear roadmap for further growth, Clinic Dermatech is defining what modern skincare and hair care should look like: personalised, science-led, and most importantly, focused on real people and safe, consistent results. As the demand for safe, effective and non-surgical aesthetic treatments grows, Clinic Dermatech remains dedicated to widening access while investing in innovation and talent.

This award is a recognition of the brand’s present and a signal of its direction in the years to come.

India, 3^rd July 2025: SOCIAL, India’s favourite neighbourhood café-bar, announces the launch of The SOCIAL Jumpstart, a new morning format crafted for anyone seeking intentional, energizing starts to their day. Starting July, The SOCIAL Jumpstart will activate mornings from 7:30 AM to 11:30 AM across key cities, transforming familiar SOCIAL outposts into high-energy spaces for movement, recovery, and real-world connection. With curated experiences, mood-lifting menus, and culture-forward brand integrations, The SOCIAL Jumpstart signals a fresh chapter in SOCIAL’s evolution, one that reclaims mornings as a vibrant, purpose-driven time to gather, move, and reset.

At its core, The SOCIAL Jumpstart is a reflection of how India’s cultural rhythm is evolving, where mornings are no longer rushed or routine, but intentional and community led. With this new format, SOCIAL extends its philosophy of creating spaces that adapt to how people live, move, and connect. From running clubs to casual breakfast seekers, the aim is to offer a morning environment that feels energizing, inclusive, and rooted in culture.

“The SOCIAL Jumpstart is our response to a cultural shift we’ve been observing for a while where mornings are becoming a space for community, clarity, and conscious living. At SOCIAL, we’ve always shaped culture through community-first formats, and this one brings together everything we believe in: movement, clean fuel, and real-world vibe. It’s not just about wellness, it’s about starting your day with intent and energy.” said Divya Aggarwal, Chief Growth Officer at Impresario Entertainment and Hospitality Pvt Ltd

To bring The SOCIAL Jumpstart to life, SOCIAL has partnered with a thoughtful mix of brands and run clubs and movement groups that share its focus on purposeful activities and community energy. Isopure has joined as the clean nutrition partner, with a special menu of smoothies and breakfast bowls designed to support recovery and fuel early mornings. Fizzy Whey (Big Muscles) brings a playful twist to the experience through a new lineup of functional mocktails, while Wellbeing Hydrasalts enhances the format with hydration support and immersive brand moments on-ground. Alongside the menus and activities, each city will see curated community gatherings that include fitness-led experiences, clean eating, and good music, all tied together by SOCIAL’s unique storytelling and cultural lens.

With The SOCIAL Jumpstart, SOCIAL is reimagining mornings as a space for culture, community, and conscious living. The format will continue to evolve with new cities, partners, and experiences that reflect how young India chooses to start its day.

Kaya, India’s most trusted chain of dermatologist-led clinics, has launched its 12th clinic in Bengaluru, marking a key milestone in its citywide expansion. The newest location in Yelahanka, one of Bengaluru’s most historic localities, blends convenience with clinical excellence. With this launch, Kaya continues its mission to make expert dermatological care accessible across every corner of the city, ensuring no neighbourhood is left behind.

The Yelahanka clinic offers a premium, state-of-the-art environment, where clients can experience a wide spectrum of signature services, ranging from US-FDA cleared laser hair reduction and rejuvenating MediFacials to advanced pigmentation correction, scar and acne solutions, PRP hair therapy, Botox, fillers, and non-invasive body contouring. Each service is delivered under the guidance of Kaya’s board-certified dermatologists and is customised for visible, lasting results.

The launch was graced by Kannada film star Sapthami Gowda, whose belief in honest, expert-led self-care beautifully echoed Kaya’s values and added star power to the occasion.

“Bengaluru is India’s innovation capital and a natural fit for Kaya’s continued growth,” said Nishant Nayyar, Head of Marketing at Kaya. “With a discerning, high-net-worth audience that values quality, visible results, and ease of access, the demand for expert-led skin and hair solutions is only growing. Yelahanka’s rich heritage and growing momentum, made it a natural choice for Kaya’s next chapter in Bengaluru.”

Sapthami Gowda added, “In an era of filters, Kaya enhances our unique features rather than masking them. Their honest, expert-driven approach resonates with me, and I know Yelahanka will embrace it wholeheartedly.”

Dr. Veena Praveen, Head Medical Advisor (South) at Kaya Clinics, noted, “Every client’s concerns tell a story. Our goal is to decode that story with compassion and evidence-based care, bringing global standards to this vibrant part of Bengaluru. With this new launch, we are also bringing new technologies like MCT – targeted to supercharge hair restoration, Aerolase – targeted to transform skin conditions like acne, anti-ageing, pigmentation etc. and Artiqa – a non-invasive technology that combines thermal shock & electro muscle stimulation and helps in skin firming and toning.”

New Delhi, July 2, 2025: Building on the momentum of a successful debut, Informa Markets in India is all set to host the second edition of the India Health Exhibition from July 11 to 13, 2025, at Bharat Mandapam, New Delhi. Positioned at the forefront of healthcare innovation and collaboration, India Health 2025 will bring together key players from across the healthcare value chain in a format designed to maximize networking, business exchange, and knowledge sharing.

The event, which emerged from the globally acclaimed legacy of WHX- Dubai (formerly Arab Health), is rapidly cementing its place as India’s premier healthcare exhibition and conference platform. With India’s healthcare sector poised to reach Rs 18.5 Bn by FY 2027, the show’s timing aligns perfectly with the industry’s urgent demand for inclusive, tech-driven, and scalable healthcare solutions.

Speaking ahead of the event, Mr. Yogesh Mudras, Managing Director, Informa Markets in India, remarked, ” The vision behind the India Health Exhibition has always been to create a meaningful space where India’s healthcare leaders, innovators, and policymakers can collaborate and co-create the future. In 2025, we are elevating that experience with new features, richer content, and stronger partnerships. India’s healthcare industry is expected to reach $638 billion by 2030, driven by rising demand, digital adoption, and strong policy reforms. The MedTech sector alone is projected to hit $50 billion, backed by PLI schemes and increased R&D.

India Health, geo-located from WHX-Dubai, is a timely response to this growth—bridging international expertise with local ambition. and the time is ripe for a platform that goes beyond showcasing—one that actively shapes dialogue, policy, and real-world impact.”

A Comprehensive Platform for Industry Collaboration

This year’s edition will feature over 300 diverse brands such as Marengo Hospitals, Midmark, Pallakad, Italian Medtech Association, DKS Ortho & Pharmalab with 95% domestic and 5% international representation. The exhibitor categories span the full spectrum of healthcare—including medical equipment and devices, diagnostics, orthopaedics, IT systems, infrastructure, and wellness solutions.

Visitors expected to exceed 8,000 professionals will include biomedical engineers, radiologists, pathologists, hospital procurement heads, clinicians, R&D professionals, and medical technology regulators. As part of its mission to democratize access and learning, the India Health Exhibition 2025 will continue to offer expansive show floor featuring innovations, product launches, and an integrated Start-Up and Medical Laboratory Pavilion.

Deep-Dive into Knowledge and Innovation

The event will also feature two different streams of robust knowledge platforms. The specially curated Global Medtech Connect, taking place on July 11 and 12 will feature over 25+ speakers and 100 delegates with subjects such as ‘Navigating Geopolitical Storms: How Indian MedTech Leaders Are Adapting to U.S. Tariff Pressures’; ‘The Role of QMS for MedTech Organizations in India: ISO 13485 and Indian MDR Alignment’; ‘Cultivating a Culture of Excellence in Medical Device Manufacturing and Strengthening India’s Medical Device Regulatory System through IMDRF Membership’; and ‘Refurbished Medical Devices: Unlocking Potential Through Regulatory Clarity and Ensuring Patient Safety’, among others.

Parallelly, the show will host over 50+ speakers tackling some of the most critical topics shaping the future of healthcare. From AI-powered diagnostics, preventive genetics, and digital transformation to sustainable practices and entrepreneurial innovation, the themes reflect the evolving priorities of the healthcare ecosystem.

A new addition this year is the B2B Matchmaking App, designed to create structured engagement between buyers and sellers and boost meaningful business interactions. The show will also host dedicated pavilions that spotlight emerging healthcare start-ups and SMEs, furthering the industry’s innovation pipeline.

Supporting Industry Growth Amid Policy and Market Shifts

As the healthcare sector navigates economic expansion and policy evolution, India Health 2025 provides a timely platform to respond to industry shifts. The Indian medical tourism market alone is projected to grow from USD 2.89 billion in 2020 to USD 13.42 billion by 2026, while rapid investment in hospital infrastructure, digital tools, and healthcare innovation continues to redefine delivery models. In a fast-moving and competitive exhibition landscape, India Health stands apart by combining deep industry engagement, practical business tools, and strong regional and domestic outreach with the legacy of a coveted international brand.

The India Health Exhibition 2025 is supported by industry bodies such as AIMED, ADMI, AHPI, EPCMD, and MTAI, ensuring it remains aligned with both sectoral priorities and the country’s broader goals under the ‘Make in India’ and ‘Digital Health Mission’ agendas.

2nd July 2025: On the occasion of National Doctors’ Day, Apollo Hospitals Chairman Dr. Prathap C. Reddy announced a renewed and historic commitment to reshape India’s health future—by doubling down on prevention-first care to combat the nation’s growing Non-Communicable Disease (NCD) crisis. Building on over four decades of clinical leadership, this strategic step reinforces Apollo’s pioneering focus on AI-powered, tech-enabled preventive health—transforming how India detects, predicts, and ultimately prevents disease.

Building on four decades of clinical leadership, this strategic step deepens Apollo’s pioneering focus on prevention, using cutting-edge technology and AI-powered intelligence to tackle the NCD crisis.

The announcement reflects a mission that began as early as 1974, when Dr. Reddy introduced India’s first structured health check. Since then, Apollo has built a globally benchmarked ecosystem—what he calls the “science of preventive health”—that has touched more than 29 million lives worldwide.

Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group, stated:
“As a doctor, I have witnessed firsthand the staggering toll that non-communicable diseases are taking on our nation — not just on health, but across our economy, our families, and our future. We are facing a silent tsunami, and the only way to fight it is by acting early. Today, with the power of artificial intelligence and evidence-based preventive programs, we have the unprecedented ability to detect risk before disease manifests — to arrest its progress, and in many cases, reverse it altogether. Prevention must become the foundation of our national health strategy.”

Fighting the NCD Tsunami: A National Mission

India faces an unprecedented health crisis—non-communicable diseases now claim 63% of all deaths, what makes this silent epidemic even more urgent is its growing toll on younger lives, cutting potential short far too soon.

The power of early detection and intervention has been scientifically validated: cardiovascular events can be prevented in 80% of cases, diabetes complications reduced by 70%, and cancer mortality decreased by 50% through systematic screening and lifestyle modification programs.

Apollo’s preventive healthcare model, which at its core houses innovations like AICVD, an AI model for early cardiovascular risk prediction; structured screening protocols for cancer, stroke, lung, and metabolic conditions which help predict NCD’s at an early stage reducing the burden on the nation. With facilities like home diagnostics, real-time digital reports; and mobile medical units reaching underserved communities Apollo’s preventive care model is designed to serve everyone, everywhere.

Apollo’s comprehensive preventive framework not only supports the Government of India’s public health priorities but also aligns with the WHO’s Sustainable Development Goals — shifting healthcare from episodic treatment to continuous wellness and placing the power of prevention in the hands of every citizen.

At the heart of this vision lies Apollo ZEN — the gold standard in preventive health. Designed as the most personalised, scientifically backed health check program in the country, ZEN integrates state-of-the-art diagnostics, AI-driven clinical insights, expert guidance from super-specialists and consistent follow-up by lifestyle medicine expert into a seamless, unified experience. It’s much more than just a health check, ZEN is a blueprint for healthy longevity.

A Message to Every Indian: A New Beginning

“To every Indian, my message this Doctors’ Day is simple yet urgent — let this be the moment we shift our mindset as a nation. Let us choose foresight over fear, action over anxiety, and wellness over wait-and-watch. The future of our health lies not in reacting to illness, but in being proactive and preventing it before it begins. We have spent four decades perfecting the science of prevention. Today, we commit ourselves to a greater purpose — to ensure that every Indian, in every corner of the country, benefits from this mastery. Your health is your greatest asset — and with Apollo’s perfected preventive care, that asset is not only protected, but optimised and continuously strengthened for the life you deserve”, stated Dr. Prathap C. Reddy, Chairman, Apollo Hospitals Group.